INVIVYD INC Share Price Today: Live Updates & Key Insights

INVIVYD INC share price today is $1.38, up -4.83%. The stock opened at $1.47 against the previous close of $1.45, with an intraday high of $1.475 and low of $1.38.

INVIVYD INC Share Price Chart

INVIVYD INC

us-stock
To Invest in {{usstockname}}
us-stock

INVIVYD INC Share Price Performance

$1.38 -0.0483(-4.83%) IVVD at 23 Mar 2026 01:44 PM Biotechnology
Lowest Today 1.38
Highest Today 1.475
Today’s Open 1.47
Prev. Close 1.45
52 Week High 3.07
52 Week Low 0.46
Day’s Range: Low 1.38 High 1.475
52-Week Range: Low 0.46 High 3.07
1 day return -
1 Week return -15.96
1 month return -13.35
3 month return -51.47
6 month return +15.28
1 year return +91.12
3 year return -2.44
5 year return -93.33
10 year return -

INVIVYD INC Institutional Holdings

HHG PLC 8.98

Point72 Asset Management, L.P. 7.18

Bvf Inc 6.91

Maverick Capital Ltd 6.71

RA Capital Management, LLC 6.06

Driehaus Capital Management LLC 4.62

Mithril II GP LP 3.98

Vanguard Group Inc 3.79

M28 Capital Management LP 3.27

Saturn V Capital Management LLC 2.74

Vanguard Total Stock Mkt Idx Inv 2.62

Eventide Asset Management, LLC 2.06

Eventide Healthcare & Life Sciences I 2.06

State Street® SPDR® S&P® Biotech ETF 1.68

Siren, L.L.C. 1.42

ADAR1 Capital Management LLC 1.38

Balyasny Asset Management LLC 1.35

Adage Capital Partners Gp LLC 1.30

683 Capital Management LLC 1.03

Redmile Group, LLC 0.81

Two Sigma Investments LLC 0.78

Ikarian Capital, LLC 0.74

Heptagon Driehaus US Micro Cap Eq C$ Acc 0.73

Geode Capital Management, LLC 0.73

Vanguard Institutional Extnd Mkt Idx Tr 0.67

MEDICAL BioHealth EUR Acc 0.37

Fidelity Extended Market Index 0.33

Driehaus Micro Cap Growth USD 0.30

Driehaus Micro Cap Growth USD 0.28

iShares Core S&P Total US Stock Mkt ETF 0.26

Blackrock Extended Mkt Fund CF 0.17

Emerald Growth A 0.15

Extended Equity Market Fund K 0.14

Adara Smaller Companies 0.14

Fidelity Total Market Index 0.12

Invesco RAFI US 1500 Small-Mid ETF 0.10

Fidelity Series Total Market Index 0.10

Spartan Extended Market Index Pool F 0.09

NT Ext Equity Mkt Idx Fd - L 0.07

Direxion Daily S&P Biotech Bull 3X ETF 0.07

INVIVYD INC Market Status

Strong Buy: 1

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

INVIVYD INC Fundamentals

Market Cap 482.20 M

PB Ratio 1.6965

PE Ratio 0.0

Enterprise Value 168.61 M

Total Assets 276.88 M

Volume 6698513

INVIVYD INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:null 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY23:-169563000 -169.6M, FY22:-234603000 -234.6M, FY21:-234289000 -234.3M, FY20:null 0.0M

Quarterly Revenue Q3/2025:13129000 13.1M, Q2/2025:11786000 11.8M, Q1/2025:11304000 11.3M, Q3/2024:9300000 9.3M, Q2/2024:2264000 2.3M

Quarterly Profit Q3/2025:12041000 12.0M, Q2/2025:11101000 11.1M, Q1/2025:10470000 10.5M, Q3/2024:8494000 8.5M, Q2/2024:2176000 2.2M

Quarterly Net worth Q3/2025:-10470000 -10.5M, Q2/2025:-14660000 -14.7M, Q1/2025:-16289000 -16.3M, Q3/2024:-60739000 -60.7M, Q2/2024:-47247000 -47.2M

About INVIVYD INC & investment objective

Company Information Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.

Organisation Biotechnology

Employees 122

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

INVIVYD INC FAQs

What is the share price of INVIVYD INC today?

The current share price of INVIVYD INC is $1.38.

Can I buy INVIVYD INC shares in India?

Yes, Indian investors can buy INVIVYD INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy INVIVYD INC shares in India?

You can easily invest in INVIVYD INC shares from India by:

Can I buy fractional shares of INVIVYD INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of INVIVYD INC?

INVIVYD INC has a market cap of $482.20 M.

In which sector does INVIVYD INC belong?

INVIVYD INC operates in the Biotechnology sector.

What documents are required to invest in INVIVYD INC stocks?

To invest, you typically need:

What is the PE and PB ratio of INVIVYD INC?

The PE ratio of INVIVYD INC is N/A and the PB ratio is 1.70.